Atopic dermatitis (AD) is a common, chronically relapsing skin condition that affects an estimated 10.7% and 7.2% of American children and adults, respectively.1,2 Atopic dermatitis is burdensome at the individual and population level, associated with reduced quality of life and substantial financial costs.
Drucker AM, Wang AR, Qureshi AA. Research Gaps in Quality of Life and Economic Burden of Atopic Dermatitis: The National Eczema Association Burden of Disease Audit. JAMA Dermatol. 2016;152(8):873–874. doi:10.1001/jamadermatol.2016.1978
Artificial Intelligence Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.